Shenzhen YHLO Biotech Co Ltd
SSE:688575

Watchlist Manager
Shenzhen YHLO Biotech Co Ltd Logo
Shenzhen YHLO Biotech Co Ltd
SSE:688575
Watchlist
Price: 14.58 CNY 2.68%
Market Cap: 8.3B CNY

Gross Margin
Shenzhen YHLO Biotech Co Ltd

64.7%
Current
57%
Average
47.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
64.7%
=
Gross Profit
1.2B
/
Revenue
1.9B

Gross Margin Across Competitors

No Stocks Found

Shenzhen YHLO Biotech Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Health Care

In the bustling city of Shenzhen, a beacon of China's rapid technological advancement, YHLO Biotech Co Ltd has emerged as a dynamic player in the healthcare diagnostics industry. Founded in 2008, YHLO Biotech focuses on the development, manufacturing, and distribution of in-vitro diagnostic products. By leveraging cutting-edge immunodiagnostic technologies, the company spearheads innovations in autoimmune disease diagnostics, infectious disease testing, and respiratory pathogen detection. Driven by a commitment to precision and reliability, YHLO Biotech integrates advanced automation solutions and robust biological research to produce diagnostic kits that serve hospitals, laboratories, and research institutions across the globe. YHLO Biotech's business model revolves around an intricate blend of product sales and strategic partnerships. By establishing a diverse portfolio of diagnostic instruments and reagent kits, they cater to both public and private healthcare sectors. The company also engages in collaborations with international diagnostic companies, enhancing its global footprint and broadening market access. Revenue generation at YHLO Biotech is primarily rooted in the sale of these diagnostic solutions, which are consistently updated to meet evolving medical standards and demands. Coupled with their investment in R&D and a rigorous quality control process, YHLO Biotech not only maintains a competitive edge but also fortifies its position as a trusted entity within the medical diagnostics landscape.

Intrinsic Value
22.86 CNY
Undervaluation 36%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
64.7%
=
Gross Profit
1.2B
/
Revenue
1.9B
What is the Gross Margin of Shenzhen YHLO Biotech Co Ltd?

Based on Shenzhen YHLO Biotech Co Ltd's most recent financial statements, the company has Gross Margin of 64.7%.

Back to Top